Skip to main content
. 2021 Mar 8;23(5):776–784. doi: 10.1002/ejhf.2134

Figure 3.

EJHF-2134-FIG-0003-c

Potassium levels over time by treatment group and mineralocorticoid receptor antagonist (MRA) treatment. No significant between‐group differences were present.